Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06467019

Informative Exhibition for Deprescribing Benzodiazepines

The goal of this trial is to determine if an interactive and informative exhibition in the waiting room of a Primary Care Clinic can reduce the use of benzodiazepines in adults. The main question it aims to answer is:

• Does an interactive and informative exhibition reduce the number of participants using benzodiazepines? Researchers will compare benzodiazepine consumption before and after the interactive and informative exhibition implementation at study center.

Participants will receive an informative and interactive exhibition on the risks of chronic benzodiazepine use. A single informative session on the same topic will be conducted for health professionals.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Benzodiazepine-Related Disorders

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women between 18 and 99 years of age.
  • Attended at the Baix-a-Mar Primary Care Center during the study period.

Exclusion criteria

  • Severe mental health disease
  • Displaced patients or those who do not have an assigned doctor at the center.
  • Participation in another study involving an experimental intervention during the period of the present study that affects benzodiazepine prescription.

Treatment and study plan

Informative Session

Other

The intervention consists of implementing an interactive exhibition on the risks of chronic benzodiazepine treatment in the waiting room of a primary care center. Additionally, the health professionals at the center will receive a single informative session on the same topic.

Primary outcomes

  1. Chronic treatment with benzodiazepines

    Time frame: 1 year

    Percentage of patients treated chronically with benzodiazepines, based on electronic prescription data.

Study contacts

Contact information is provided by the study sponsor or research team.

Jordi Milozzi, MD

CONTACT

[email protected]

+34 938 10 30 03

Noemí Casaponsa

CONTACT

[email protected]

+34 938960025 ext. 43197

Sponsors and collaborators

Lead sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Other

Registry information

Official study title

Impact of an Interactive and Informative Exhibition on Benzodiazepine Use on Deprescription.

Acronym: ESUB

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jun 20, 2024
Registry last updated
Jun 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.